CG Oncology (CGON) EBITDA Margin (2023 - 2026)
CG Oncology's EBITDA Margin came in at -7394.21% for Q2 2026, down 1341.76 percentage points from the prior quarter.
Powered by 
Analysis
CG Oncology (CGON) EBITDA Margin (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, CG Oncology reported EBITDA Margin of -4008.72%, up 24500.90 percentage points year-over-year; for FY2025, it was -4686.36%, up 5378.08 percentage points from FY2024.
- Going back by year, EBITDA Margin was -10064.44% in FY2024 (+17108.11 pp) and -27172.55% in FY2023.
- The Q2 2026 figure represents the lowest quarterly EBITDA Margin since Q1 2025.
- Year-over-year, EBITDA Margin increased in five of the last six quarters, with an average year-over-year change of +347361.21 percentage points.
- Business Quant data shows CGON's EBITDA Margin at -6052.45% (Q1 2026), -2060.77% (Q4 2025) and -3044.00% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.50 Bn | 1,103.09 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 616.20 Bn | 534.73 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 500.82 Bn | 473.93 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 367.31 Bn | 321.69 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 297.77 Bn | 261.76 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.35 Bn | 235.04 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 235.40 Bn | 190.80 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 190.59 Bn | 164.79 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 169.39 Bn | 116.04 Bn | 10.94 Bn | 39.16% |
| 10 | CG Oncology | 5.49 Bn | 1.96 Bn | -2.77 Mn | -7,394.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7,394.21% |
| Mar 31, 2026 | -6,052.45% |
| Dec 31, 2025 | -2,060.77% |
| Sep 30, 2025 | -3,044.00% |
| Mar 31, 2025 | -81,115.38% |
| Dec 31, 2024 | -8,344.08% |
| Sep 30, 2024 | -65,753.49% |
| Jun 30, 2024 | -23,284.68% |
| Mar 31, 2024 | -4,246.69% |
| Dec 31, 2023 | -1,936,000.00% |
| Sep 30, 2023 | -155,922.22% |
| Mar 31, 2023 | -5,005.15% |
API Access
CG Oncology EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CGON&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CGON", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CGON&period=max&api_key=YOUR_API_KEY");
const data = await res.json();